Barden Capital Management
CL icon

Barden Capital Management’s Colgate-Palmolive CL Stock Holding History

Barden Capital Management’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.1M Buy
12,857
+59
+0.5% +$5.34K 1% 31
2026
Q2 		$1.17M Buy
+12,798
New +$1.12M 1.08% 31

Other funds holding CL

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Barden Capital Management's CL Position: Q3 2026 in Review

Barden Capital Management increased its Colgate-Palmolive (CL) stake by 0.46% in Q3 2026, buying an estimated $5.34K and bringing the position to 12,857 shares worth $1.1M. The position accounts for 1% of the portfolio, ranked #31.

Barden Capital Management first reported a position in CL in Q2 2026 and has held it in 2 quarters since. The position peaked at $1.17M in Q2 2026. 1,712 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Barden Capital Management held 12,857 shares of Colgate-Palmolive worth $1.1M as of Q3 2026.
  • Barden Capital Management bought 59 Colgate-Palmolive shares in Q3 2026, an estimated $5.34K.
  • Colgate-Palmolive made up 1% of Barden Capital Management's portfolio in Q3 2026, its #31 holding.
  • Barden Capital Management first reported a position in Colgate-Palmolive in Q2 2026 and has held it in 2 quarters since.
  • Barden Capital Management's Colgate-Palmolive position peaked at $1.17M in Q2 2026.
  • 1,712 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Barden Capital Management's 13F filing for Q3 2026, filed 9 Oct 2026.